Skip to main content
. 2021 Oct 19;12:169–184. doi: 10.1016/j.bioactmat.2021.10.017

Fig. 5.

Fig. 5

A) Expression level of osteogenesis-related genes including RUNX2, OCN, OPN (n = 3, all values were mean ± std. dev., NS, not significant, **p < 0.01, ***p < 0.001, ****p < 0.0001 when comparing A-H + AB-O and other groups; #p < 0.05, ##p < 0.01 when comparing Control and A-H via two-way ANOVA analysis followed by Tukey's multiple comparison test by GraphPad Prism 7.0 Software (USA)). B) Expression level of osteoclastogenesis-related genes including MMP-9, c-FOS, NFATc1 on day 5 (n = 3, all values were mean ± std. dev., NS, not significant, **p < 0.01, ***p < 0.001, ****p < 0.0001 when comparing A-H + AB-O and other groups; #p < 0.05, ##p < 0.01, ###p < 0.001 when comparing Control and A-H; &p < 0.05, &&p < 0.01, &&&p < 0.01 when comparing A-H and A-H + AB via one-way ANOVA analysis followed by Tukey's multiple comparison test by GraphPad Prism 7.0 Software (USA)).